Lv1
74 积分 2024-01-11 加入
Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival
5个月前
已完结
A Phase 1/2 Multicenter Randomized Trial of Local Ablation plus Toripalimab versus Toripalimab Alone for Previously Treated Unresectable Hepatocellular Carcinoma
7个月前
已完结
Progression-free survival: it is time for a new name
7个月前
已完结
Machine learning-based development and validation of a scoring system for progression-free survival in liver cancer
8个月前
已完结
Liver cancer in 2021: Global Burden of Disease study
8个月前
已完结
Epidemiology, pathophysiology and clinical aspects of Hepatocellular Carcinoma in MAFLD patients
8个月前
已完结
Management changes and survival outcomes for cancer patients after multidisciplinary team discussion; a systematic review and meta-analysis
11个月前
已完结
Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma
11个月前
已完结
Combination locoregional and systemic therapies in hepatocellular carcinoma
11个月前
已完结
Hepatic arterial infusion chemotherapy versus transarterial chemoembolization, potential conversion therapies for single huge hepatocellular carcinoma: a retrospective comparison study
1年前
已完结
皖公网安备34019202002308
